KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Enterprise Value (2016 - 2025)

Elevance Health (ELV) has disclosed Enterprise Value for 17 consecutive years, with -$35.2 billion as the latest value for Q4 2025.

  • Quarterly Enterprise Value fell 5.55% to -$35.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$35.2 billion through Dec 2025, down 5.55% year-over-year, with the annual reading at -$35.2 billion for FY2025, 5.55% down from the prior year.
  • Enterprise Value for Q4 2025 was -$35.2 billion at Elevance Health, down from -$9.8 billion in the prior quarter.
  • The five-year high for Enterprise Value was -$6.7 billion in Q4 2023, with the low at -$37.7 billion in Q1 2023.
  • Average Enterprise Value over 5 years is -$22.6 billion, with a median of -$32.3 billion recorded in 2021.
  • The sharpest move saw Enterprise Value surged 79.98% in 2023, then plummeted 401.47% in 2024.
  • Over 5 years, Enterprise Value stood at -$6.7 billion in 2021, then tumbled by 396.82% to -$33.3 billion in 2022, then soared by 79.98% to -$6.7 billion in 2023, then tumbled by 401.47% to -$33.4 billion in 2024, then decreased by 5.55% to -$35.2 billion in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$35.2 billion, -$9.8 billion, and -$33.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.